Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non Alcoholic Fatty Liver Disease (NAFLD)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT06026293
What this trial is testing

Pharmacoeconomic Evaluation of the Cost/effectiveness Ratio of Physical Exercise on Non-alcoholic Fatty Liver Disease

Who this might be right for
Non-Alcoholic Fatty Liver Disease
Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis 58
Testing effectiveness (Phase 2)Study completedNCT02546609
What this trial is testing

The Effect Of NS-0200 Versus Placebo On Hepatic Fat Content In Patients With Non Alcoholic Fatty Liver Disease

Who this might be right for
NAFLD
NuSirt Biopharma 91
Testing effectiveness (Phase 2)Temporarily pausedNCT00546455
What this trial is testing

A Randomized, Double-blind Study of the Effects of Fenretinide Administered in Subjects With Obesity

Who this might be right for
ObesityInsulin Resistance
University of California, San Diego 21
Not applicableStudy completedNCT05370053
What this trial is testing

The Availability of the Enhanced Liver Fibrosis (ELF) Test Affects the Rate of Diagnosis of Nonalcoholic Steatohepatitis (NASH) With Fibrosis in Patients Referred to Hepatology

Who this might be right for
Fatty LiverNAFLD
University of Kansas Medical Center 450
Not applicableWithdrawnNCT02194894
What this trial is testing

The Effect of Acetaminophen on Non-alcoholic Fatty Liver Disease Patients

Who this might be right for
Non-alcoholic Fatty Liver Disease (NAFLD)
University of Southern California
Not applicableStudy completedNCT06389851
What this trial is testing

Effects of Tomato Consumption on Steatosis, Intestinal Function and Glucose and Lipid Metabolism in Subjects With NAFLD

Who this might be right for
NAFLDIBS
Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis 80
Not applicableStudy completedNCT04859322
What this trial is testing

The Effect of Lifestyle-induced Hepatic Steatosis on Glucagon-stimulated Amino Acid Turnover

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseGlucagon Resistance
Malte Palm Suppli, MD 20
Testing effectiveness (Phase 2)Ended earlyNCT04065841
What this trial is testing

Efficacy, Safety and Tolerability of the Combination of Tropifexor & Licogliflozin and Each Monotherapy, Compared With Placebo in Adult Patients With NASH and Liver Fibrosis.

Who this might be right for
Non Alcoholic Steatohepatitis (NASH)
Novartis Pharmaceuticals 234
Not applicableStudy completedNCT07146815
What this trial is testing

PolyCystic Ovary Syndrome as Suggested Risk Group for Non-Alcoholic Fatty Liver Disease

Who this might be right for
NAFLD (Nonalcoholic Fatty Liver Disease)Polycystic Ovarian Syndrome (PCOS)
Ziekenhuis Oost-Limburg 157
Not applicableUnknownNCT05301231
What this trial is testing

Omics-based Predictors of NAFLD/Potential NASH

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseNon Alcoholic Steatohepatitis
National Research Centre, Egypt 450
Not applicableStudy completedNCT01966627
What this trial is testing

Genetics of Fatty Liver Disease in Children

Who this might be right for
Non Alcoholic Fatty Liver Disease
Yale University 381
Not applicableUnknownNCT05971082
What this trial is testing

Risk Factors for Advanced Fibrosis Among FLD Patients

Who this might be right for
NAFLDLiver CirrhosisDiabetes Mellitus, Type 2
Helsinki University Central Hospital 1,000
Not applicableActive Not RecruitingNCT04383951
What this trial is testing

Safety and Efficacy of Ketogenic Diet for Promoting Weight Loss in Obese Individuals With Compensated NASH Cirrhosis

Who this might be right for
NASH - Nonalcoholic SteatohepatitisCirrhosis, Liver
Indiana University 40
Not applicableStudy completedNCT03663062
What this trial is testing

ObeSity Related Colorectal Adenoma Risk

Who this might be right for
Colorectal AdenomaColorectal NeoplasmColorectal Cancer+4 more
South Tyneside and Sunderland NHS Foundation Trust 1,430
Not applicableStudy completedNCT03985020
What this trial is testing

Super HEROES: Searching How the Extract Rebaudioside Occludes Excess Steatosis

Who this might be right for
Non-Alcoholic Fatty Liver Disease
Children's Hospital Los Angeles 20
Early research (Phase 1)Study completedNCT04686994
What this trial is testing

Study to Evaluate the Safety and Efficacy of ASC41 in Overweight and Obese Subjects

Who this might be right for
Overweight and ObesityNAFLDHyperlipidemia
Gannex Pharma Co., Ltd. 20
Testing effectiveness (Phase 2)Study completedNCT00668070
What this trial is testing

A Proof-of-principle Study of Oral Treatment of Non-alcoholic Steatohepatitis With a Novel PDE4 Inhibitor ASP9831

Who this might be right for
Non-Alcoholic Steatohepatitis
Astellas Pharma Inc 114
Not applicableWithdrawnNCT05130346
What this trial is testing

Effects of Mindfulness Based Stress Reduction Intervention in Patients With Non-alcoholic Fatty Liver Disease

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseFatty Liver, NonalcoholicObesity
Virginia Commonwealth University
Not applicableLooking for participantsNCT07376486
What this trial is testing

Duodenal pulsENDO as an Early Treatment for Type 2 DM

Who this might be right for
Diabete MellitusT2 Diabetes and Fatty Liver Disease (Non-alcoholic Origin)
Chinese University of Hong Kong 40
Not applicableWithdrawnNCT03163810
What this trial is testing

See if Low Level Laser Light Therapy (LLLT) Can Improve the Condition of Nonalcoholic Steatohepatitis (NASH)

Who this might be right for
Nonalcoholic Steatohepatitis
Erchonia Corporation
Next Page